Century Capital Management’s NovoCure NVCR Stock Holding History

Century Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,418	Closed	-$251K	–	199
2016 Q3	$251K	Hold	29,418	–	–	0.03%	201
2016 Q2	$343K	Hold	29,418	–	–	0.04%	201
2016 Q1	$426K	Sell	29,418 -103,421	-78%	-$1.48M	0.05%	205
2015 Q4	$2.97M	Buy	+132,839	New	+$3.17M	0.17%	158

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

CCM

Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Century Capital Management's NVCR Position: Q4 2016 in Review

Century Capital Management sold out of NovoCure (NVCR) in Q4 2016, closing a stake of 29,418 shares — an estimated $251K sold.

Century Capital Management first reported a position in NVCR in Q4 2015 and held it in 4 quarters. The position peaked at $2.97M in Q4 2015. 78 funds tracked by Wall St. Rank hold NVCR as of Q4 2016.

Century Capital Management reported no remaining NovoCure position as of Q4 2016 after selling out during the quarter.
Century Capital Management sold 29,418 NovoCure shares in Q4 2016, an estimated $251K.
Century Capital Management first reported a position in NovoCure in Q4 2015 and held it in 4 quarters.
Century Capital Management's NovoCure position peaked at $2.97M in Q4 2015.
78 funds tracked by Wall St. Rank held NovoCure as of Q4 2016.

Based on Century Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.